Other OTC Pharmaceuticals (Pharmacies) - Netherlands

  • Netherlands
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$100.90m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.44%, resulting in a market volume of US$102.70m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$5.71 are generated in 2024.

Key regions: United Kingdom, Canada, France, Europe, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Netherlands is experiencing steady growth due to various factors.

Customer preferences:
Customers in the Netherlands have a high demand for over-the-counter (OTC) pharmaceuticals, which can be attributed to several reasons. Firstly, the Dutch healthcare system emphasizes self-care and encourages individuals to take responsibility for their own health. As a result, many consumers prefer to treat minor ailments and common health issues with OTC medications, rather than seeking medical advice. Secondly, the convenience of purchasing OTC pharmaceuticals from pharmacies is highly valued by customers, as it allows them to access necessary medications without a prescription. Additionally, the widespread availability of information on the internet has empowered consumers to make informed decisions about their health and choose suitable OTC products.

Trends in the market:
One notable trend in the Other OTC Pharmaceuticals market in the Netherlands is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as more natural and less chemically-based. This trend is driven by a desire for alternative treatment options and a preference for products with fewer potential side effects. As a result, pharmacies are expanding their offerings of natural and herbal OTC products to cater to this growing demand. Another trend in the market is the rise of online sales of OTC pharmaceuticals. The convenience and accessibility of online shopping have led to a significant increase in e-commerce for healthcare products. Customers can now easily compare prices, read reviews, and make purchases from the comfort of their own homes. This shift towards online sales has prompted pharmacies to develop their online presence and invest in digital marketing strategies to attract and retain customers.

Local special circumstances:
The Netherlands has a highly developed healthcare system, which includes a strong network of pharmacies. Pharmacies in the Netherlands play a vital role in providing healthcare services and advice to the population. They are well-regulated and adhere to strict quality standards, ensuring that customers have access to safe and effective OTC pharmaceuticals. Additionally, the Dutch government has implemented policies to control the prices of OTC medications, making them affordable and accessible to a wide range of consumers.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals market in the Netherlands can also be attributed to favorable macroeconomic factors. The country has a stable economy, with a high GDP per capita and a strong healthcare infrastructure. The Netherlands has a well-developed pharmaceutical industry, with both domestic and international companies operating in the market. This competitive landscape encourages innovation and drives the development of new OTC products. Furthermore, the aging population in the Netherlands contributes to the demand for OTC pharmaceuticals, as older individuals often require medications for chronic conditions and age-related health issues. In conclusion, the Other OTC Pharmaceuticals market in the Netherlands is experiencing growth due to customer preferences for self-care, the increasing demand for natural and herbal remedies, the rise of online sales, the importance of pharmacies in the healthcare system, and favorable macroeconomic factors.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)